Optic Pathway Glioma Treatment: A Mini-review of the Current Literature

Background and Aim: Optic pathway glioma (OPG) is a chronic condition that needs multidisciplinary management strategy. Most of these tumors are observed in the pediatric population tumor tends to stabilize after child’s growth. This benign course can be mostly neurofibromatosis 1 (NF1) patients, which about half patients. Methods Materials/Patients: The current literature PubMed Scopus databases was searched. recent data regarding OPG treatment options were reviewed design this narrative mini-review. Results: brief extracted from 17 articles, cited reference list, included study. Conclusion: Chemotherapy first best modality for patients with OPG. It more useful at younger ages because it has lower rates complications cancer future compared radiotherapy, choice previous decades However, practice, been substituted by chemotherapy its serious adverse effects on population. Neurosurgical treatments used three main purposes, third ventricle obstruction-related hydrocephalus, biopsy, tissue diagnosis cases an uncertain diagnosis, decompression due mass effect vital structures. Surgical not considered first-line progressive exophthalmos ipsilateral blindness or refractory pain adjuvant treatment. short review discusses aspects modalities.